Posts

SRI spins off AI-powered drug discovery platform Synfin...

SRI International announced today it is spinning off Synfini, a biosciences plat...

Researchers fabricate chip-based optical resonators wit...

WASHINGTON — Researchers have created chip-based photonic resonators that operat...

New material captures coronavirus particles and could t...

A research team at the University of Liverpool has developed a new material that...

WVU researcher to help send swarm of marine robots on c...

Research from West Virginia University mechanical and aerospace engineer Xi Yu c...

RPI researcher of circadian rhythms receives $2 million...

With daylight savings time ending soon, we anticipate a change in the timing of ...

Double trouble: Infamous “eagle killer” bacterium produ...

The cyanobacterium Aetokthonos hydrillicola produces not just one, but two highl...

Smart carts could detect fire hazards in nuclear facili...

A University of Texas at Arlington researcher is working with a not-for-profit c...

Living donor liver transplant access is optimal for hig...

“Access to LDLT in a transplant program can optimize the timing of transplant fo...

THE LANCET: Gender inequalities worsen women’s access t...

Peer reviewed / Review, analysis and opinion Credit: The Lancet Peer reviewed / ...

A novel role discovered for vagus nerve

The vagus nerve, known for its role in ‘resting and digesting’, has now been fou...

Patients who quit smoking after percutaneous coronary i...

Patients who quit smoking after undergoing percutaneous coronary intervention (P...

Valneva receives JE vaccine supply contract from US DoD

Valneva has received a contract from the US Department of Defense (DoD) for the ...

Merck and ICR enter renewed cancer drug discovery partn...

Merck KGaA and the ICR have entered into a renewed strategic collaboration to di...

Boehringer and Lilly gain FDA approval for kidney disea...

Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to...

New Alzheimer’s disease medication approved in Japan

Eisai and BioArctic’s Leqembi is the only approved treatment that slows cognitiv...

Pierre Fabre announces another partnership to expand on...

Pierre Fabre will fund the discovery and development of multiple small-molecule ...